Lipid peroxidation, protein oxidation, and mutations in mitochondrial DNA generate reactive oxygen species (ROS) that are involved in cell death and inflammatory response syndrome. ROS can also act as a signal in the intracellular pathways involved in normal cell growth and homeostasis, as well as in response to metabolic adaptations, autophagy, immunity, differentiation and cell aging, the latter of which is an important characteristic in acute and chronic pathologies. Thus, the measurement of ROS levels of critically ill patients, upon admission, enables a prediction not only of the severity of the inflammatory response, but also of its subsequent potential outcome. The aim of this study was to measure the levels of mitochondrial ROS (superoxide anion) in the peripheral blood lymphocytes within 24 h of admission and correlate them with survival at one year after ICU and hospital discharge. We designed an observational prospective study in 51 critical care patients, in which clinical variables and ROS production were identified and correlated with mortality at 12 months post-ICU hospitalization. Oxidative stress levels, measured as DHE fluorescence, show a positive correlation with increased long-term mortality. In ICU patients the major determinant of survival is oxidative stress, which determines inflammation and outlines the cellular response to inflammatory stimuli.
31 March 2025 in Journal of Parenteral and Enteral Nutrition
Background: Patients with critical illness may present with disease‐related malnutrition upon intensive care unit (ICU) admission. They are at risk of development and progression of malnutrition over the disease trajectory because of inflammation, dysregulated metabolism, and challenges with feeding.Methods: The Global Leadership Initiative on Malnutrition (GLIM) convened a panel of 36 clinical nutrition experts to develop consensus‐based guidance statements addressing the diagnosis of malnutrition during critical illness using a modified Delphi approach with a requirement of ≥75% agreement.Results: (1) To identify pre‐existing malnutrition, we suggest evaluation within 48 h of ICU admission when feasible (100% agreement) or within 4 days (94% agreement). (2) To identify the development and progression of malnutrition, we suggest re‐evaluation of all patients every 7–10 days (97% agreement). (3) To identify progressive loss of muscle mass, we suggest evaluation of muscle mass as soon as feasible (92% agreement) and again after 7–10 days (89% agreement). (4) To identify the development and progression of malnutrition before and after ICU discharge, we suggest re‐evaluating nutrition status before ICU discharge and during clinical visits that follow (100% agreement).Conclusion: Research using consistent etiologic and phenotypic variables offers great potential to assess the efficacy of nutrition interventions for critically ill patients with malnutrition. Assessment of these variables during and beyond the ICU stay will clarify the trajectory of malnutrition and enable exploration of impactful treatment modalities at each juncture. GLIM offers a diagnostic approach that can be used to identify malnutrition in critically ill patients.
Patients with critical illness may present with disease-related malnutrition upon intensive care unit (ICU) admission. They are at risk of development and progression of malnutrition over the disease trajectory because of inflammation, dysregulated metabolism, and challenges with feeding. The Global Leadership Initiative on Malnutrition (GLIM) convened a panel of 36 clinical nutrition experts to develop consensus-based guidance statements addressing the diagnosis of malnutrition during critical illness, using a modified Delphi approach with a requirement of ≥75% agreement. CONCLUSION: Research using consistent etiologic and phenotypic variables offers great potential to assess the efficacy of nutrition interventions for critically ill patients with malnutrition. Assessment of these variables at during and beyond the ICU stay will clarify the trajectory of malnutrition and enable exploration of impactful treatment modalities at each juncture. GLIM offers a diagnostic approach that can be used to identify malnutrition in critically ill patients.
Para emitir las recomendaciones específicas frente a la población de pacientes con cáncer, se tomaron en cuenta diversas observaciones en pacientes con patologías oncológicas en momentos de COVID-19, que muestran riesgo mayor de complicaciones en esta población, así como las recomendaciones publicadas por las siguientes instituciones y asociaciones: National Comprehensive Cancer Network (NCCN), American College of Surgeons (ACS), American Society of Clinical Oncology (ASCO), European Society of Surgical Oncology (ESSO), Society of Surgical Oncology (SSO) y Asociación Española de Cirujanos (AEC).
La pandemia por el virus SARS-CoV-2 y la enfermedad generada (COVID-19, del inglés Coronavirus 2019 Disease), llevó a nivel mundial a cambios significativos en la forma de prestar los servicios de salud, incluida la actividad quirúrgica. Como parte de esta realidad, se recomendó en Colombia la adopción de disposiciones enfocadas a preparar nuestro sistema de salud para enfrentar una avalancha de pacientes COVID-19, que se esperaba fuera similar a la presentada en otros países. Las medidas se tomaron en el momento oportuno, ganando tiempo de preparación, sin que hasta la fecha (8 semanas después del primer caso diagnosticado en Colombia) se haya desbordado la demanda de atención, modificando la forma esperada de la curva epidemiológica, con un número menor de pacientes.
La hospitalización domiciliaria es un modelo de atención eficiente y eficaz que permite mejorar el uso de los recursos en salud. Dentro de este modelo de atención se incluye la terapia nutricional especializada, que da continuidad a las intervenciones intrahospitalarias a pacientes malnutridos y específicamente en pacientes con falla intestinal, cuya única terapia nutricional posible, es la terapia parenteral. La nutrición parenteral domiciliaria (NPD) es un programa multifactorial cuya adecuada implementación genera resultados excelentes, reduciendo costos de atención en salud. Para este artículo se llevó a cabo una revisión de las publicaciones referentes a terapia parenteral domiciliaria, y se adicionó la experiencia profesional de losautores, como miembros del comité nutricional, de una de las instituciones de atención domiciliaria en Colombia.